Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.

John B LiaoWilliam R GwinRenata R UrbanKatie M Hitchcock-BernhardtAndrew L CovelerDoreen M HigginsJennifer S ChildsHania N ShakaliaRon E SwensenSasha E StantonAnna V TinkerTanya A WahlRichard G AnchetaKathryn F McGonigleJames Y DaiMary L DisisBarbara A Goff

Published in: Journal for immunotherapy of cancer (2022)

NCT03029598.

Keyphrases

low dose
papillary thyroid
high dose
squamous cell
phase ii study
advanced non small cell lung cancer
free survival
squamous cell carcinoma
lymph node metastasis
randomized controlled trial
phase iii
childhood cancer
study protocol